BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$7.52 USD
-0.33 (-4.20%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $7.51 -0.01 (-0.13%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: BMO |
6/2024 | $-0.19 | -8.62% |
Earnings Summary
For their last quarter, BioCryst Pharmaceuticals (BCRX) reported earnings of -$0.17 per share, beating the Zacks Consensus Estimate of $-0.23 per share. This reflects a positive earnings surprise of 26.09%. Look out for BCRX's next earnings release on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 20.83%.
Earnings History
Price & Consensus
Zacks News for BCRX
BioCryst (BCRX) Upgraded to Strong Buy: Here's Why
BCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services